ASY.PA vs. CORT
Compare and contrast key facts about Assystem S.A. (ASY.PA) and Corcept Therapeutics Incorporated (CORT).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: ASY.PA or CORT.
Key characteristics
| ASY.PA | CORT | |
|---|---|---|
| YTD Return | -11.31% | 83.50% |
| 1Y Return | 8.40% | 139.26% |
| 3Y Return (Ann) | 14.42% | 37.49% |
| 5Y Return (Ann) | 8.51% | 31.81% |
| 10Y Return (Ann) | 13.41% | 34.61% |
| Sharpe Ratio | 0.17 | 2.44 |
| Sortino Ratio | 0.46 | 2.66 |
| Omega Ratio | 1.06 | 1.42 |
| Calmar Ratio | 0.16 | 3.50 |
| Martin Ratio | 0.49 | 7.38 |
| Ulcer Index | 12.25% | 17.80% |
| Daily Std Dev | 34.78% | 53.90% |
| Max Drawdown | -94.84% | -94.28% |
| Current Drawdown | -34.93% | 0.00% |
Fundamentals
| ASY.PA | CORT | |
|---|---|---|
| Market Cap | €555.87M | $5.46B |
| EPS | €6.79 | $1.31 |
| PE Ratio | 5.46 | 39.80 |
| PEG Ratio | 0.00 | 0.61 |
| Total Revenue (TTM) | €596.30M | $628.56M |
| Gross Profit (TTM) | €173.70M | $618.75M |
| EBITDA (TTM) | €40.20M | $144.87M |
Correlation
The correlation between ASY.PA and CORT is 0.06, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
ASY.PA vs. CORT - Performance Comparison
In the year-to-date period, ASY.PA achieves a -11.31% return, which is significantly lower than CORT's 83.50% return. Over the past 10 years, ASY.PA has underperformed CORT with an annualized return of 13.41%, while CORT has yielded a comparatively higher 34.61% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
ASY.PA vs. CORT - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Assystem S.A. (ASY.PA) and Corcept Therapeutics Incorporated (CORT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
ASY.PA vs. CORT - Dividend Comparison
ASY.PA's dividend yield for the trailing twelve months is around 21.00%, while CORT has not paid dividends to shareholders.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ASY.PA Assystem S.A. | 21.00% | 2.02% | 2.46% | 2.67% | 4.07% | 3.10% | 3.70% | 3.34% | 3.02% | 3.12% | 2.57% | 2.24% |
CORT Corcept Therapeutics Incorporated | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
ASY.PA vs. CORT - Drawdown Comparison
The maximum ASY.PA drawdown since its inception was -94.84%, roughly equal to the maximum CORT drawdown of -94.28%. Use the drawdown chart below to compare losses from any high point for ASY.PA and CORT. For additional features, visit the drawdowns tool.
Volatility
ASY.PA vs. CORT - Volatility Comparison
Assystem S.A. (ASY.PA) has a higher volatility of 19.70% compared to Corcept Therapeutics Incorporated (CORT) at 14.33%. This indicates that ASY.PA's price experiences larger fluctuations and is considered to be riskier than CORT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
ASY.PA vs. CORT - Financials Comparison
This section allows you to compare key financial metrics between Assystem S.A. and Corcept Therapeutics Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities